Correction: Isatin-based benzyloxybenzene derivatives as monoamine oxidase inhibitors with neuroprotective effect targeting neurodegenerative disease treatment

RSC Adv. 2024 Jan 2;14(1):538. doi: 10.1039/d3ra90123h.

¹ Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus Kochi 682041 India febacbenny@gmail.com solankimedchem@gmail.com bijovilaventgu@gmail.com bijomathew@aims.amrita.edu.
² Department of Pharmacy, Research Institute of Life Pharmaceutical Sciences, Sunchon National University Suncheon 57922 Republic of Korea ddazzo005@naver.com hoon@sunchon.ac.kr.
³ Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University Sakaka 72341 Saudi Arabia mhmdgwd@ju.edu.sa.
⁴ Department of Pharmacy Practice, College of Pharmacy, AlMaarefa University Ad Diriyah 13713 Saudi Arabia mghoneim@mcst.edu.sa.
⁵ Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University Buraydah 51452 Saudi Arabia abdelbakkym@yahoo.com.
⁶ School of Pharmacy, Graphic Era Hill University Dehradun Uttarakhand 248002 India nkukreti@gehu.ac.in.
⁷ Department of Pharmaceutics, NGSM Institute of Pharmaceutical Science, NITTE University Mangalore Karnataka 575018 India jjmattam07@gmail.com.

Abstract

[This corrects the article DOI: 10.1039/D3RA07035B.].